Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Caroli Erkrankung

Die angeborene zystische Dilatation der intrahepatischen Gallenwege wird als Caroli-Syndrom bezeichnet. Ätiologisch kommen neben PKHD1-Mutationen (autosomal dominant) sicher auch andere bisher noch nicht ausreichend charakterisierte Gene in Betracht.

Gliederung

Erbliche Lebererkrankungen
Acoeruloplasminämie/Hypocoeruloplasminämie
Budd-Chiari-Syndrom
Caroli Erkrankung
PKHD1
Genetisch bedingte Hyperbilirubinämie
Hepatitis B-Infektionsanfälligkeit
Hepatozelluläres Karzinom
Hämochromatose
Ivemark-Syndrom
Morbus Fabry
Polyzystische Lebererkrankung
Trichohepatoenterisches Syndrom

Referenzen:

1.

Guay-Woodford LM et al. (1995) The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: implications for genetic counseling.

external link
2.

Luthy DA et al. (1985) Infantile polycystic kidney disease: observations from attempts at prenatal diagnosis.

external link
3.

Gang DL et al. (1986) Infantile polycystic disease of the liver and kidneys.

external link
4.

Adams CM et al. (1974) Comments upon the classification of infantile polycystic diseases of the liver and kidney, based upon three-dimensional reconstruction of the liver.

external link
5.

Isdale JM et al. (1973) Infantile polycystic disease of the kidneys.

external link
6.

Blyth H et al. (1971) Polycystic disease of kidney and liver presenting in childhood.

external link
7.

Turnberg LA et al. (1968) Biliary secretion in a patient with cystic dilation of the intrahepatic biliary tree.

external link
8.

Blyth HM et al. (1969) A clinico-pathological and family study of polycystic disease of the kidneys and liver in children.

external link
9.

Hunter FM et al. (1966) Congenital dilation of the intrahepatic bile ducts.

external link
10.

Mandell J et al. (1983) Congenital polycystic kidney disease. Genetically transmitted infantile polycystic kidney disease in C57BL/6J mice.

external link
11.

Schmidt W et al. (1982) Genetics, pathoanatomy and prenatal diagnosis of Potter I syndrome and other urogenital tract diseases.

external link
12.

Naveh Y et al. (1980) Congenital hepatic fibrosis with congenital heart disease. A family study with ultrastructural features of the liver.

external link
13.

Deget F et al. (1995) Course of autosomal recessive polycystic kidney disease (ARPKD) in siblings: a clinical comparison of 20 sibships.

external link
14.

Ward CJ et al. (2002) The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

external link
15.

Iakoubova OA et al. (1995) Localization of a murine recessive polycystic kidney disease mutation and modifying loci that affect disease severity.

external link
16.

Zerres K et al. (1994) Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen.

external link
17.

Mücher G et al. (1994) Refining the map and defining flanking markers of the gene for autosomal recessive polycystic kidney disease on chromosome 6p21.1-p12.

external link
18.

Simon EA et al. (1994) The mouse congenital polycystic kidney (cpk) locus maps within 1.3 cM of the chromosome 12 marker D12Nyu2.

external link
19.

Nakamura T et al. (1993) Growth factor gene expression in kidney of murine polycystic kidney disease.

external link
20.

Ros E et al. (1993) Ursodeoxycholic acid treatment of primary hepatolithiasis in Caroli's syndrome.

external link
21.

Moyer JH et al. (1994) Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice.

external link
22.

Atala A et al. (1993) Juvenile cystic kidneys (jck): a new mouse mutation which causes polycystic kidneys.

external link
23.

Gattone VH et al. (1996) Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.

external link
24.

Nagao S et al. (1995) Genetic mapping of the polycystic kidney gene, pcy, on mouse chromosome 9.

external link
25.

Woo DD et al. (1997) Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice.

external link
26.

Richards WG et al. (1998) Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.

external link
27.

Cowley BD et al. (1987) Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease.

external link
28.

Janaswami PM et al. (1997) Identification and genetic mapping of a new polycystic kidney disease on mouse chromosome 8.

external link
29.

Boichis H et al. (1973) Congenital hepatic fibrosis and nephronophthisis. A family study.

external link
30.

Liu S et al. (2002) A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish.

external link
31.

Zerres K et al. (1984) Cystic kidneys. Genetics, pathologic anatomy, clinical picture, and prenatal diagnosis.

external link
32.

Gupta GK et al. (2000) Urinary basic fibroblast growth factor: a noninvasive marker of progressive cystic renal disease in a child.

external link
33.

None (2002) Another cystic mystery solved.

external link
34.

Guay-Woodford LM et al. (2003) Autosomal recessive polycystic kidney disease: the clinical experience in North America.

external link
35.

Bosch BM et al. (2003) Autosomal recessive polycystic kidney disease: improvement of renal function.

external link
36.

Bergmann C et al. (2005) Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD).

external link
37.

Adeva M et al. (2006) Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).

external link
38.

Zerres K et al. (1998) Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology.

external link
39.

Upadhya P et al. (1999) Genetic modifiers of polycystic kidney disease in intersubspecific KAT2J mutants.

external link
40.

Guay-Woodford LM et al. (2000) Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated.

external link
41.

Omran H et al. (2001) Human adolescent nephronophthisis: gene locus synteny with polycystic kidney disease in pcy mice.

external link
42.

CAROLI J et al. (1958) [Congenital polycystic dilation of the intrahepatic bile ducts; attempt at classification].

external link
43.

LUNDIN PM et al. (1961) Polycystic kidneys in newborns, infants and children. A clinical and pathological study.

external link
44.

Bukanov NO et al. (2006) Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.

external link
45.

Davisson MT et al. (1991) The mouse polycystic kidney disease mutation (cpk) is located on proximal chromosome 12.

external link
46.

Martínez-Frías ML et al. (1991) Epidemiological aspects of Mendelian syndromes in a Spanish population sample: II. Autosomal recessive malformation syndromes.

external link
47.

Kaplan BS et al. (1989) Autosomal recessive polycystic kidney disease.

external link
48.

Ramsay M et al. (1988) Mutations for the autosomal recessive and autosomal dominant forms of polycystic kidney disease are not allelic.

external link
49.

Zerres K et al. (1988) Autosomal recessive polycystic kidney disease. Problems of prenatal diagnosis.

external link
50.

Kaplan BS et al. (1988) Variable expression of autosomal recessive polycystic kidney disease and congenital hepatic fibrosis within a family.

external link
51.

Wirth B et al. (1987) Autosomal recessive and dominant forms of polycystic kidney disease are not allelic.

external link
52.

None (1987) Polycystic kidney disease in children: a genetic and epidemiological study of 82 Finnish patients.

external link
53.

OMIM.ORG article

Omim 600643 external link
54.

Orphanet article

Orphanet ID 53035 external link
55.

Wikipedia Artikel

Wikipedia DE (Caroli-Syndrom) external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz